NEW YORK (GenomeWeb) – Interpace Diagnostics reported today that its first quarter revenues rose 43 percent year over year, thanks in part to 60 percent growth in the number of tests accessioned.

For the quarter ended March 31, the molecular diagnostics developer reported revenues of $3.0 million compared to revenues of $2.1 million the year before.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.